Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.

Campbell, John D et al.·The Journal of experimental medicine·2009·
RPEP-014622009RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.
Published In:
The Journal of experimental medicine, 206(7), 1535-47 (2009)
Database ID:
RPEP-01462

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01462·https://rethinkpeptides.com/research/RPEP-01462

APA

Campbell, John D; Buckland, Karen F; McMillan, Sarah J; Kearley, Jennifer; Oldfield, William L G; Stern, Lawrence J; Grönlund, Hans; van Hage, Marianne; Reynolds, Catherine J; Boyton, Rosemary J; Cobbold, Stephen P; Kay, A Barry; Altmann, Daniel M; Lloyd, Clare M; Larché, Mark. (2009). Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.. The Journal of experimental medicine, 206(7), 1535-47. https://doi.org/10.1084/jem.20082901

MLA

Campbell, John D, et al. "Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.." The Journal of experimental medicine, 2009. https://doi.org/10.1084/jem.20082901

RethinkPeptides

RethinkPeptides Research Database. "Peptide immunotherapy in allergic asthma generates IL-10-dep..." RPEP-01462. Retrieved from https://rethinkpeptides.com/research/campbell-2009-peptide-immunotherapy-in-allergic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.